Repurposing FDA-Approved Drugs and Exploring Nutraceuticals for Diabetes Management via Molecular Docking and ADMET Analysis
The findings suggest that glycyrrhetinic acid, berberine, metformin, and linagliptin may warrant further experimental evaluation as candidates or reference compounds in diabetes-related drug discovery and require biological validation before therapeutic relevance can be confirmed in future diabetes research and practic...